PILOT TRIAL OF AN ADJUVANT PENTAVALENT VACCINE FOR PATIENTS WITH SMALL CELL LUNG CANCER (SCLC)

被引：0
|
作者：
Krug, Lee M. [1 ]
Varghese, Anna [1 ]
Ragupathi, Govind [2 ]
George, Constantine [2 ]
Sawada, Ritsuko [3 ]
Scholz, Wolfgang W. [3 ]
Hansen, David [3 ]
Livingston, Philip O. [3 ]
Delasos, Lukas [1 ]
Pietanza, Maria C. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, Thorac Oncol Serv, Dept Med, New York, NY USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY USA
[3] Mabvax Therapeut, San Diego, CA USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
small cell lung cancer; vaccine; immunotherapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.13-007
引用
收藏
页码：S1231 / S1232
页数：2
相关论文
共 50 条
  • [21] Prognostic factors in Greek patients with small cell lung cancer (SCLC). A Hellenic Cooperative Oncology Group Study
    Christodoulou, C
    Pavlidis, N
    Samantas, E
    Fountzilas, G
    Kouvatseas, G
    Pagdatoglou, K
    Palamidas, F
    Nikolaidis, C
    Angelidou, M
    Kalofonos, HP
    Kosmidis, P
    Skarlos, DV
    ANTICANCER RESEARCH, 2002, 22 (6B) : 3749 - 3757
  • [22] Genomic Associations of Chemoimmunotherapy Outcomes in a Real-World Cohort of Small Cell Lung Cancer (SCLC) Patients
    Ullah, A. T.
    Quintanilha, J.
    Graf, R.
    Oxnard, G.
    Riess, J. W.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S367 - S368
  • [23] Carboplatin in Combination with Bendamustine in Previously Untreated Patients with Extensive-Stage Small Cell Lung Cancer (SCLC)
    Wolf Köster
    G. Stamatis
    A. Heider
    K. Avramidis
    H. Wilke
    J.A. Koch
    M. Stahl
    Clinical Drug Investigation, 2004, 24 : 611 - 618
  • [24] Epidermal growth factor vaccine in non-small-cell lung cancer
    Gonzalez Marinello, Gisela M.
    Santos, Edgardo S.
    Raez, Luis E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (04) : 439 - 445
  • [25] Small cell lung carcinoma (SCLC): the angiogenic phenomenon
    Lucchi, M
    Mussi, A
    Fontanini, G
    Faviana, P
    Ribechini, A
    Angeletti, CA
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 21 (06) : 1105 - 1110
  • [26] SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)
    Domine, M.
    Moran, T.
    Isla, D.
    Marti, J. L.
    Sullivan, I.
    Provencio, M.
    Olmedo, M. E.
    Ponce, S.
    Blasco, A.
    Cobo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2020, 22 (02) : 245 - 255
  • [27] SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019)
    M. Dómine
    T. Moran
    D. Isla
    J. L. Martí
    I. Sullivan
    M. Provencio
    M. E. Olmedo
    S. Ponce
    A. Blasco
    M. Cobo
    Clinical and Translational Oncology, 2020, 22 : 245 - 255
  • [28] Targeting Mitochondrial Metabolism as a Selective Therapeutic Approach in Small Cell Lung Cancer (SCLC)
    Chowdhury, S. Roy
    Saleh, R.
    Girard, C.
    Peltier, C.
    Desautels, D.
    Dawe, D.
    Banerji, V.
    Banerji, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S970 - S970
  • [29] Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)
    Ding, Xiao-Long
    Su, Yi-Ge
    Yu, Liang
    Bai, Zhou-Lan
    Bai, Xue-Hong
    Chen, Xiao-Zhen
    Yang, Xia
    Zhao, Ren
    He, Jin-Xi
    Wang, Yan-Yang
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2022, 20 (01)
  • [30] Clinical characteristics and patient outcomes of molecular subtypes of small cell lung cancer (SCLC)
    Xiao-Long Ding
    Yi-Ge Su
    Liang Yu
    Zhou-Lan Bai
    Xue-Hong Bai
    Xiao-Zhen Chen
    Xia Yang
    Ren Zhao
    Jin-Xi He
    Yan-Yang Wang
    World Journal of Surgical Oncology, 20
12345